logo-loader
viewKromek Group PLC

Kromek Group PLC - Director Share Purchase

RNS Number : 0677X
Kromek Group PLC
17 December 2019
 

17 December 2019

 

Kromek Group plc

("Kromek" the "Company" or the "Group")

 

Director Share Purchase

 

Kromek (AIM: KMK), a worldwide supplier of detection technology focusing on the medical, security and civil nuclear markets, announces that Christopher Wilks, a Non-executive Director of the Company, yesterday purchased 50,000 ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") at a price of 21.95 pence per Ordinary Share.

 

Following this purchase, Mr Wilks has an interest in 175,000 Ordinary Shares, representing 0.05% of the issued share capital of the Company. 

 

 

For further information, please contact:

Kromek Group plc


Arnab Basu, CEO
Derek Bulmer, CFO

 

+44 (0)1740 626 060

Cenkos Securities plc (Nominated Adviser and Broker)


Max Hartley (NOMAD)
Julian Morse (Sales)

 

+44 (0)20 7397 8900

Luther Pendragon (PR)


Harry Chathli
Claire Norbury
Alexis Gore

Joe Quinlan

+44 (0)20 7618 9100

 

The Company makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulation:

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Christopher Wilks

 

2

Reason for the notification

a)

Position/status

Non-executive Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Kromek Group plc

b)

LEI

213800VLHYXGHEX5VQ48

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1p each

 

GB00BD7V5D43

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

21.95 pence

50,000

 

d)

Aggregated information

- Aggregated volume
- Price

 

 N/A

e)

Date of the transaction

16 December 2019

f)

Place of the transaction

London Stock Exchange

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHEAAAKFALNFAF

Quick facts: Kromek Group PLC

Price: 14.75

Market: AIM
Market Cap: £50.83 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Kromek Group CEO details DARPA extension and 'groundbreaking' pathogen...

Kromek Group PLC's (LON:KMK) Dr Arnab Basu speaks to Proactive London's Andrew Scott after reporting they've been awarded an extension to its contract with the Defense Advanced Research Projects Agency (DARPA) to detect and identify pathogens in an urban environment. Under the deal it will be...

on 27/5/20